NAFTA at 25: A New Beginning? (Pt 2/2)
Sometime later this year NAFTA 2.0, the US-Mexico-Canada Agreement (USMCA), is supposed to go into effect. Is it an improvement over the old NAFTA in any way? We speak to…
Sometime later this year NAFTA 2.0, the US-Mexico-Canada Agreement (USMCA), is supposed to go into effect. Is it an improvement over the old NAFTA in any way? We speak to…
Ending patent monopolies and prosecuting big pharma will drive prescription drug prices down, says Alex Lawson, Executive Director of Social Security Works Subscribe to our page and support our work…
One of the Trump administration’s promises leading up to 2020 is to reduce prescription drug prices, but the plan has stalled after a big court loss, and other blows to…
It’s definitely just a coincidence that one of Trump’s coronavirus task force members is a former lobbyist for Gilead Sciences, the company that won orphan drug status for its COVID-19…
This week, President Biden announced that, by utilizing the Defense Production Act, the federal government has created an historic agreement between drugmakers Johnson & Johnson and Merck to produce enough…
Update 8/30/21: At the 6:40 mark in the video, PhRMA is referred to as a 501(c)(3) organization, but the correct classification is 501(c)(6). We regret the error and are posting…
America’s most popular TV host, Tucker Carlson, continues to share baseless COVID-19 conspiracy theories with his millions of Fox News viewers while comparing vaccine mandates to authoritarian overreach. In reality,…